Talix

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Caedo Oncology

This company develops monoclonal antibody therapeutics that induce programmed cell death in cancer cells for healthcare providers and patients.

Avidicure

This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.

LiliumX

This biotechnology company develops a discovery platform and bispecific antibody-drug conjugates for the treatment of cancer and other complex diseases.

Tentarix Biotherapeutics, LP

This biotechnology company develops conditionally active multispecific biologics for pharmaceutical partners to treat oncology and autoimmune diseases.